Tuan S. Nguyen

Researcher Profile 5/10

Viet Duc Hospital · Medicine and Pharmacy

59 publications · 1,377 citations · h-index 14

Information

🏛️Affiliation: Viet Duc Hospital
🔬Field: Medicine and Pharmacy
✍️Profile incomplete — add information

An h-index of 14 places this researcher in Medicine and Pharmacy, within the top 10% of 6,619 profiles in this field in our directory.

Featured publications

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors766 citations
Cancer Discovery · 2016 · DOI

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma126 citations
Journal of Clinical Oncology · 2016 · DOI

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy76 citations
Clinical Cancer Research · 2015 · DOI

Thymidylate Synthase Expression and Outcome of Patients Receiving Pemetrexed for Advanced Nonsquamous Non–Small-Cell Lung Cancer in a Prospective Blinded Assessment Phase II Clinical Trial60 citations
Journal of Thoracic Oncology · 2013 · DOI

Analysis of recent pediatric orthotopic liver transplantation outcomes indicates that allograft type is no longer a predictor of survivals51 citations
Liver Transplantation · 2008 · DOI

Phase 2 study of tabalumab, a human anti‐B‐cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma49 citations
British Journal of Haematology · 2016 · DOI

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-1944 citations
European Respiratory Journal · 2021 · DOI

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenström Macroglobulinemia29 citations
Clinical Cancer Research · 2012 · DOI

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer28 citations
Journal of Clinical Oncology · 2013 · DOI

Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma22 citations
Clinical Cancer Research · 2016 · DOI

About the field of Medicine and Pharmacy

6,619researchers 91,896publications 2,589,484citations 4.2average h-index

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field: